Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002389831 | SCV002702035 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-01-29 | criteria provided, single submitter | clinical testing | The c.1498_1504dupGCCAGAG pathogenic mutation, located in coding exon 9 of the MSH2 gene, results from a duplication of GCCAGAG at nucleotide position 1498, causing a translational frameshift with a predicted alternate stop codon (p.D502Gfs*13). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |